Degarelix trials for Prostate cancer

All Degarelix trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Degarelix for Prostate cancer

• A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
  NCT07335796 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
  NCT07455903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
  NCT05873192 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
  NCT03678025 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 338 locations
• Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
  NCT06378866 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations
• Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
  NCT04734730 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations

Common questions

How many trials study Degarelix for Prostate cancer?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.